Biogen scraps development of therapy for rare brain disease
(Reuters) – Biogen Inc said on Friday it would discontinue the development of its experimental therapy for a rare brain disease after the treatment failed a mid-stage trial, the latest…
Sarepta shares surge after surprise approval of Duchenne Muscular Dystrophy drug
(Reuters) – Shares of Sarepta Therapeutics Inc (SRPT.O) soared 36% on Friday after U.S. regulators shocked Wall Street by approving the company’s treatment for a muscle-wasting disorder less than four…
Bankrupt PG&E reaches $13.5 billion settlement with California wildfire victims
(Reuters) – California’s bankrupt power producer PG&E Corp (PCG.N) said on Friday it had reached a $13.5 billion settlement with victims of some of most devastating wildfires in the state’s…
Half of lymphoma patients alive three years after Gilead cell therapy treatment: study
(Reuters) – Nearly half of lymphoma patients treated with Gilead Sciences Inc’s Yescarta were alive at least three years after a one-time infusion of the CAR-T cell therapy, according to…
Proxy adviser ISS opposes plan by Hudson’s Bay chairman to take firm private
(Reuters) – Institutional Shareholder Services said on Friday it recommends shareholders vote against a plan by the chairman of Hudson’s Bay Co to take the Saks Fifth Avenue owner private…
Factbox: Alphabet’s ‘Other bets’ in focus as Google’s Pichai takes helm
(Reuters) – Google Chief Executive Officer Sundar Pichai will replace Larry Page as CEO of parent Alphabet Inc, heralding a new chapter for the company that helped reshape the global…
BlackRock global active equities chief to leave firm over relationship with colleague
(Reuters) – Mark Wiseman, global head of active equities at BlackRock Inc (BLK.N), is leaving the firm following a violation of the company’s “relationships at work policy,” the world’s largest…
Wall Street inches higher as Dec. 15 tariff deadline looms
NEW YORK (Reuters) – Wall Street eked out slight gains on Thursday as investors waited for concrete news on a hoped-for interim trade deal between the United States and China…
Wall Street bides its time, awaiting news from trade front
NEW YORK (Reuters) – Wall Street was largely unchanged on Thursday as market participants stayed on the sidelines, awaiting further developments in the hoped-for interim trade deal between the United…
UK bribery investigation adds to Glencore’s legal headaches
LONDON (Reuters) – The UK’s Serious Fraud Office (SFO) has launched a bribery investigation into Glencore (GLEN.L), adding to legal troubles that have hit the shares of one of the…